NCT02600325 - Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 1, 2018

Study Completion Date

January 11, 2019

Conditions

Acute Hepatitis CHuman Immunodeficiency VirusHepatitis C

Interventions

DRUG

Grazoprevir/Elbasvir 100mg/50mg

Trial Locations (9)

Institute of Tropical Medicine Antwerp (ITG), Antwerp

Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam

Slotervaart Hospital, Amsterdam

Rijnstate Hospital, Arnhem

University Medical Center Groningen (UMCG), Groningen

Maastricht University Medical Center (MUMC), Maastricht

Radbout University Medical Center, Nijmegen

Utrecht Medical University Center (UMCU), Utrecht

Erasmus Medical Center (EMC), Rotterdam